In a study evaluating the long‐term outcomes of coronary artery bypass graft surgery (CABG) in patients with CAD, the presence of T2D resulted in increased morbidity and mortality over the first 10 years following the surgery, and this increase was exacerbated in patients taking anti‐hyperglycemic medications and insulin (Kogan et al., 2018). Here, INS is linked to type 2 diabetes mellitus.